Skip to main content

Quipt Home Medical Schedules Special Shareholder Meeting for March

Tipranks - Wed Jan 7, 4:00PM CST

Claim 70% Off TipRanks Premium

Quipt Home Medical ( (TSE:QIPT) ) has issued an update.

On December 30, 2025, Quipt Home Medical Corp. announced it had issued a notice of meeting for a special meeting of shareholders scheduled to take place in Sarasota, Florida, on March 3, 2026. The company set January 22, 2026 as the record date for notice, voting, and beneficial ownership determination, and confirmed it will send proxy-related materials directly to non-objecting beneficial owners and cover delivery costs for objecting beneficial owners, underscoring its efforts to ensure broad shareholder participation in the upcoming governance-related proceedings.

The most recent analyst rating on (TSE:QIPT) stock is a Buy with a C$5.50 price target. To see the full list of analyst forecasts on Quipt Home Medical stock, see the TSE:QIPT Stock Forecast page.

Spark’s Take on TSE:QIPT Stock

According to Spark, TipRanks’ AI Analyst, TSE:QIPT is a Outperform.

Quipt Home Medical’s overall score is driven by strong technical momentum and strategic expansions, despite profitability challenges and valuation concerns. The company’s ability to generate cash and strategic partnerships provide a positive outlook, but improvements in profitability are necessary for long-term growth.

To see Spark’s full report on TSE:QIPT stock, click here.

More about Quipt Home Medical

Quipt Home Medical Corp. operates in the healthcare sector, providing home medical equipment and related services to patients, with a focus on supporting care in the home environment through equipment supply and associated support services.

Average Trading Volume: 40,244

Technical Sentiment Signal: Hold

Current Market Cap: C$214.9M

See more insights into QIPT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.